cGxP.wire https://validator.w3.org/feed/docs/rss2.html Nanobiotix Updates Phase 3 NANORAY-312 Protocol Opus Genetics Enters FDA RDEP Program for OPGx-LCA5 Cellenkos Secures FDA IND Clearance for CK0802 in GVHD Trial Johnson & Johnson Highlights CAPLYTA Superiority in MDD Study Telix Pharmaceuticals Publishes TLX250-Px Kidney Study TriSalus Life Sciences Launches PREDICTT Trial Caris Life Sciences Gains MolDX Approval for ChromoSeq MMI Launches REMIND Trial Using Symani System UCB to Acquire Candid Therapeutics in $2.2B Immunology Deal Castle Biosciences Unveils TissueCypher Data at DDW 2026 ADMA Biologics Gains FDA Nod to Expand ASCENIV Aktis Oncology Starts Phase 1b Trial for AKY-2519 Oncolytics Biotech Reports Strong mCRC Response Data Ascidian Therapeutics Advances ACDN-01 in Stargardt Trial Insmed Unveils Phase 3 ARIKAYCE Data at ATS 2026 GRIN Therapeutics Initiates Phase 3 Beeline Study Atossa Gains FDA RPD Status for Z-Endoxifen in MAS ARCHIMED to Acquire Esperion Therapeutics in $1.1B Deal Celcuity Reports Phase 3 Success for Gedatolisib in Breast Cancer BioCryst, Neopharmed Sign $345M Europe HAE Deal Moleculent Raises $20M to Scale Functional Profiling Platform Cue Biopharma Expands Anti-IgE Pipeline in $691M Deal Eton Pharmaceuticals Relaunches HEMANGEOL for Infants MapLight Therapeutics Completes Phase 2 CNS Trials Enrollment Harvard Study Shows AI Outperforms Doctors in Diagnosis Incyte Corporation Wins FDA Approval for Jakafi XR Vector Science & Therapeutics Files Patent for Platform Everads Injector Shows Strong Results in Retinal Study Specialised Therapeutics NIKTIMVO Approved for cGVHD Rezolute, Inc. Reports Phase 3 sunRIZE Data in HI BioMarin VOXZOGO Shows Long-Term Growth Benefits SK Capital Partners Sells Noramco Group to Siegfried Scribe Therapeutics Showcases CRISPR and STX-1150 Data Neurocrine CRENESSITY Shows 2-Year Pediatric Benefits Arvinas Inc Gains FDA Approval for VEPPANU PROTAC Drug Rhythm Pharmaceuticals Secures EU Approval for IMCIVREE Kodiak KSI-101 Shows Strong MESI Clinical Trial Results Noema Pharma AG Shows Strong Phase 2a Menopause Results Vanda Launches NEREUS First Motion Sickness Drug Pfizer ELREXFIO Phase 3 Trial Improves Survival Outcomes Pluristyx and Qkine Sign Strategic iPSC Distribution Deal Sonire Therapeutics Launches U.S. HIFU Trial in Cancer Arrowhead REDEMPLO siRNA Drug Approved in Australia InspireMD Initiates U.S. Recall of CGuard Prime System Alcresta Therapeutics Shows RELiZORBneo Benefit Data Viatris Low-Dose Estrogen Patch Phase 3 Data Update InspireMD, Inc. Secures FDA IDE for CGUARDIANS III LEO Pharma Acquires Replay to Boost Gene Therapy Sydnexis, Inc. Advances SYD-101 Data in Myopia Trial Merck Enpatoran Enters Phase 3 Trial for Lupus Treatment